In line with previous findings, CRLS1 knockdown reduced CL levels (Figure 4b; Figure S7b, Supporting Information), whereas CL replenishment reversed these effects in PD models (Figure 4c). The gene discussed is CRLS1; the disease is Parkinson disease.